Concepedia

Vivekananda Budamagunta

VB

12

Publications

850

Citations

12

H-Index

2020

Active since

Affiliations

University of Florida(Current)

The University of Texas Health Science Center at San Antonio

ID Genomics (United States)

Florida College

Institut thématique Génétique, génomique et bioinformatique

Vivekananda Budamagunta is an author at University of Florida specializing in medicine, tumor biology, and cancer research.

Top concepts

Publications per year

2020–2024

12

Publications

12

Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity

Yonghan He, Xuan Zhang, Jianhui Chang et al. · Nature Communications · 2020 · 246 citations · Full text

DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas

Yonghan He, Raphael Koch, Vivekananda Budamagunta et al. · Journal of Hematology & Oncology · 2020 · 118 citations · Full text

Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity

Yonghan He, Wen Li, Dongwen Lv et al. · Aging Cell · 2020 · 108 citations · Full text

Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL–Specific Degrader DT2216

Dinesh Thummuri, Sajid Khan, Patrick W. Underwood et al. · Molecular Cancer Therapeutics · 2021 · 67 citations · Full text

Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines

Xuan Zhang, Yonghan He, Peiyi Zhang et al. · European Journal of Medicinal Chemistry · 2020 · 60 citations · Full text

, , +8

Rows per page

1–5 of 12